Salidroside treatment restored antioxidant enzyme levels, inhibited expression of CYP2E1 and Nox2 mRNA in liver, which prevented the initial step of generating free radicals from NASH. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.